 | |
| Legal status | |
|---|---|
| Legal status | |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C23H28N2O |
| Molar mass | 348.490 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
CUMYL-PICA (SGT-56) is anindole-3-carboxamide basedsynthetic cannabinoid. It is the α,α-dimethylbenzyl analogue ofSDB-006.[1] It was briefly sold in New Zealand during 2013 as an ingredient of at the time legalsynthetic cannabis products, but the product containing CUMYL-BICA and CUMYL-PICA was denied an interim licensing approval under thePsychoactive Substances regulatory scheme, due to reports of adverse events in consumers.[2] CUMYL-PICA acts as anagonist for thecannabinoid receptors, withKi values of 59.21 nM atCB1 and 136.38 nM atCB2 andEC50 values of 11.98 nM at CB1 and 16.2 nM at CB2.[3][4]
 | Thiscannabinoid related article is astub. You can help Wikipedia byexpanding it. |
